Reference health

Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3 mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women

https://doi.org/10.3109/09513590.2015.1062860
CiteStamped reference-health badge
26/26 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

4 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 26 checked references that resolve
resolves10.1016/j.ajog.2004.01.058
State of the art in hormonal contraception: an overview
resolves10.1007/s11154-011-9182-4
Metabolic effects of contraceptive steroids
resolves10.1093/humupd/dmi046
New progestagens for contraceptive use
resolves10.1080/13697130902905757
Different cardiovascular effects of progestins according to structure and activity
resolves10.1016/0002-9378(93)90432-I
Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives
resolves10.2165/00003495-197816060-00003
When the Pill Causes a Rise in Blood Pressure
resolves10.1097/00000441-197807000-00004
Estrogens and hypertension
resolves10.1016/0010-7824(89)90001-2
The WHO multicentre trial of the vasopressor effects of combined oral contraceptives
resolves10.1016/0010-7824(89)90002-4
The WHO multicentre trial of the vasopressor effects of combined oral contraceptives: 2. Lack of effect of estrogen
resolves10.1161/01.CIR.94.3.483
Prospective Study of Oral Contraceptives and Hypertension Among Women in the United States
resolves10.1210/jcem-39-5-882
Effects of Progesterone and Four Synthetic Progestagens on Sodium Balance and the Renin-Aldosterone System in Man*†
resolves10.1016/0039-128X(96)00007-4
Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure
resolves10.1080/13625187.2002.11949331
Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing
resolves10.1210/jcem-73-4-837
Dihydrospirorenone, a New Progestogen with Antimineralocorticoid Activity: Effects on Ovulation, Electrolyte Excretion, and the Renin-Aldosterone System in Normal Women
resolves10.3109/09513590009167721
Fluid retention with oral contraceptives
resolves10.1161/01.HYP.0000150859.47929.8e
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
resolves10.1093/clinchem/37.10.1811
Plasma renin activity and plasma prorenin assays
resolves10.1016/j.contraception.2011.08.017
A combined oral contraceptive containing drospirenone changes neither endothelial function nor hemodynamic parameters in healthy young women: a prospective clinical trial
resolves10.1016/j.ejogrb.2014.01.006
Effects of a contraceptive containing drospirenone and ethinyl estradiol on blood pressure and autonomic tone: a prospective controlled clinical trial
resolves10.1016/j.contraception.2004.12.005
Effects of two combined oral contraceptives containing ethinyl estradiol 20 μg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism
resolves10.1080/09513590701325731
Influence of a new oral contraceptive with drospirenone on lipid metabolism
resolves10.1016/j.contraception.2003.11.003
A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles
resolves10.1016/j.ejogrb.2014.03.021
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women
resolves10.1016/j.contraception.2008.09.002
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial
resolves10.1016/S0010-7824(00)00196-7
Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel
resolves10.1016/0010-7824(92)90103-Z
A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel
The 4 references without a DOI — listed, not checked
no DOI — not checkedCIT0005
no DOI — not checkedCIT0017
no DOI — not checkedMedical eligibility criteria for contraceptive use
no DOI — not checkedCIT0027
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.3109/09513590.2015.1062860"><img src="https://citestamp.com/citestamped/10.3109/09513590.2015.1062860/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.3109/09513590.2015.1062860/badge.svg)](https://citestamp.com/citestamped/10.3109/09513590.2015.1062860)